These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20386440)
21. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events. Terpening C J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633 [TBL] [Abstract][Full Text] [Related]
22. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Bhatt DL Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708 [TBL] [Abstract][Full Text] [Related]
31. Predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy. Amsallem M; Manzo-Silberman S; Dillinger JG; Sideris G; Voicu S; Bal dit Sollier C; Drouet L; Henry P Am J Cardiol; 2015 May; 115(9):1305-10. PubMed ID: 25759104 [TBL] [Abstract][Full Text] [Related]
32. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
33. Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention. Robinson A; Das K; Koshy SK; Das P Future Cardiol; 2009 May; 5(3):237-46. PubMed ID: 19450050 [TBL] [Abstract][Full Text] [Related]
34. A brief review of the past and future of platelet P2Y12 antagonist. Barn K; Steinhubl SR Coron Artery Dis; 2012 Sep; 23(6):368-74. PubMed ID: 22735090 [TBL] [Abstract][Full Text] [Related]
35. Facts and controversies of aspirin and clopidogrel therapy. Faxon DP; Freedman JE Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409 [TBL] [Abstract][Full Text] [Related]
36. Update on oral antiplatelet therapy: principles, problems and promises. Grove EL; Kristensen SD Future Cardiol; 2009 May; 5(3):247-58. PubMed ID: 19450051 [TBL] [Abstract][Full Text] [Related]
37. Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery. Sousa-Uva M; Storey R; Huber K; Falk V; Leite-Moreira AF; Amour J; Al-Attar N; Ascione R; Taggart D; Collet JP; Eur Heart J; 2014 Jun; 35(23):1510-4. PubMed ID: 24748565 [No Abstract] [Full Text] [Related]
38. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Wallentin L; Varenhorst C; James S; Erlinge D; Braun OO; Jakubowski JA; Sugidachi A; Winters KJ; Siegbahn A Eur Heart J; 2008 Jan; 29(1):21-30. PubMed ID: 18055486 [TBL] [Abstract][Full Text] [Related]